Current Advances in the Management of Diabetes Mellitus.
Chinyere AlokeChinedu Ogbonnia EgwuPatrick Maduabuchi AjaNwogo Ajuka ObasiJennifer Adaeze ChukwuBlessing Oluebube AkumaduPatience Nkemjika OgbuIkechukwu AchilonuPublished in: Biomedicines (2022)
Diabetes mellitus (DM) underscores a rising epidemic orchestrating critical socio-economic burden on countries globally. Different treatment options for the management of DM are evolving rapidly because the usual methods of treatment have not completely tackled the primary causes of the disease and are laden with critical adverse effects. Thus, this narrative review explores different treatment regimens in DM management and the associated challenges. A literature search for published articles on recent advances in DM management was completed with search engines including Web of Science, Pubmed/Medline, Scopus, using keywords such as DM, management of DM, and gene therapy. Our findings indicate that substantial progress has been made in DM management with promising results using different treatment regimens, including nanotechnology, gene therapy, stem cell, medical nutrition therapy, and lifestyle modification. However, a lot of challenges have been encountered using these techniques, including their optimization to ensure optimal glycemic, lipid, and blood pressure modulation to minimize complications, improvement of patients' compliance to lifestyle and pharmacologic interventions, safety, ethical issues, as well as an effective delivery system among others. In conclusion, lifestyle management alongside pharmacological approaches and the optimization of these techniques is critical for an effective and safe clinical treatment plan.
Keyphrases
- gene therapy
- stem cells
- blood pressure
- physical activity
- cardiovascular disease
- systematic review
- healthcare
- type diabetes
- public health
- chronic kidney disease
- end stage renal disease
- ejection fraction
- skeletal muscle
- fatty acid
- bone marrow
- patient reported outcomes
- replacement therapy
- hypertensive patients
- chemotherapy induced